Add to ORKGTreatment of tuberculosis in a region with high drug resistance: Outcomes, drug resistance amplification and re-infectio
To describe the incidence of extensive drug-resistant tuberculosis (XDR-TB) reported in the Peruvian...
Tuberculosis (TB) is caused by a bacterium called Mycobacterium tuberculosis usually attack the lung...
BACKGROUND: Increasing access to drugs for the treatment of multidrug-resistant (MDR) tuberculosis i...
Introduction: Emerging antituberculosis drug resistance is a serious threat for tuberculosis (TB) co...
Emerging antituberculosis drug resistance is a serious threat for tuberculosis (TB) control, especia...
WHO estimates that 9 million people developed active tuberculosis in 2013 and 1.5 million people die...
INTRODUCTION: Emerging antituberculosis drug resistance is a serious threat for tuberculosis (TB) c...
Introduction Emerging antituberculosis drug resistance is a serious threat for tuberculosis (TB) co...
International audienceThe incidence of drug-resistant tuberculosis is no longer increasing and signi...
Currently, no information is available on the effect of resistance/susceptibility to first-line drug...
BACKGROUND Patients with highly drug-resistant forms of tuberculosis have limited treatment options ...
Tuberculosis is the leading infectious cause of death worldwide, with 9·6 million cases and 1·5 mill...
BACKGROUND: Extensively drug-resistant tuberculosis has been reported in 45 countries, including cou...
The objective: to determine factors influencing treatment efficacy in patients with multiple (MDR) a...
Alberto Matteelli,1 Alberto Roggi,1 Anna CC Carvalho21Institute of Infectious and Tropical Diseases,...
To describe the incidence of extensive drug-resistant tuberculosis (XDR-TB) reported in the Peruvian...
Tuberculosis (TB) is caused by a bacterium called Mycobacterium tuberculosis usually attack the lung...
BACKGROUND: Increasing access to drugs for the treatment of multidrug-resistant (MDR) tuberculosis i...
Introduction: Emerging antituberculosis drug resistance is a serious threat for tuberculosis (TB) co...
Emerging antituberculosis drug resistance is a serious threat for tuberculosis (TB) control, especia...
WHO estimates that 9 million people developed active tuberculosis in 2013 and 1.5 million people die...
INTRODUCTION: Emerging antituberculosis drug resistance is a serious threat for tuberculosis (TB) c...
Introduction Emerging antituberculosis drug resistance is a serious threat for tuberculosis (TB) co...
International audienceThe incidence of drug-resistant tuberculosis is no longer increasing and signi...
Currently, no information is available on the effect of resistance/susceptibility to first-line drug...
BACKGROUND Patients with highly drug-resistant forms of tuberculosis have limited treatment options ...
Tuberculosis is the leading infectious cause of death worldwide, with 9·6 million cases and 1·5 mill...
BACKGROUND: Extensively drug-resistant tuberculosis has been reported in 45 countries, including cou...
The objective: to determine factors influencing treatment efficacy in patients with multiple (MDR) a...
Alberto Matteelli,1 Alberto Roggi,1 Anna CC Carvalho21Institute of Infectious and Tropical Diseases,...
To describe the incidence of extensive drug-resistant tuberculosis (XDR-TB) reported in the Peruvian...
Tuberculosis (TB) is caused by a bacterium called Mycobacterium tuberculosis usually attack the lung...
BACKGROUND: Increasing access to drugs for the treatment of multidrug-resistant (MDR) tuberculosis i...